NextGen Healthcare Inc. [NASDAQ: NXGN] traded at a high on 01/25/23, posting a 5.80 gain after which it closed the day’ session at $18.07. The company report on January 24, 2023 that NextGen Healthcare Reports Fiscal 2023 Third Quarter Results.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Raises Full Year Revenue Guidance and Reaffirms Earnings.
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal third quarter ended December 31, 2022.
The results of the trading session contributed to over 2985174 shares changing hands. Over the past one week, the price volatility of NextGen Healthcare Inc. stands at 3.85% while the volatility over the past one month is 2.76%.
The market cap for NXGN stock reached $1.21 billion, with 67.81 million shares outstanding and 55.01 million shares in the current float. Compared to the average trading volume of 717.72K shares, NXGN reached a trading volume of 2985174 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about NextGen Healthcare Inc. [NXGN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NXGN shares is $21.19 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NXGN stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for NextGen Healthcare Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 21, 2022. While these analysts kept the previous recommendation, Truist raised their target price to Hold. The new note on the price target was released on September 07, 2022, representing the official price target for NextGen Healthcare Inc. stock. Previously, the target price had yet another raise to $26, while Guggenheim analysts kept a Buy rating on NXGN stock.
The Average True Range (ATR) for NextGen Healthcare Inc. is set at 0.55, with the Price to Sales ratio for NXGN stock in the period of the last 12 months amounting to 1.97. The Price to Book ratio for the last quarter was 2.77, with the Price to Cash per share for the same quarter was set at 1.06. Price to Free Cash Flow for NXGN in the course of the last twelve months was 18.74 with Quick ratio for the last quarter at 1.30.
How has NXGN stock performed recently?
NextGen Healthcare Inc. [NXGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.15. With this latest performance, NXGN shares dropped by -4.94% in over the last four-week period, additionally sinking by -2.85% over the last 6 months – not to mention a drop of -3.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NXGN stock in for the last two-week period is set at 48.58, with the RSI for the last a single of trading hit 53.27, and the three-weeks RSI is set at 47.04 for NextGen Healthcare Inc. [NXGN]. The present Moving Average for the last 50 days of trading for this stock 18.98, while it was recorded at 17.44 for the last single week of trading, and 18.42 for the last 200 days.
NextGen Healthcare Inc. [NXGN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and NextGen Healthcare Inc. [NXGN] shares currently have an operating margin of +1.86 and a Gross Margin at +48.72. NextGen Healthcare Inc.’s Net Margin is presently recorded at +0.27.
Return on Equity for this stock inclined to 0.38, with Return on Assets sitting at 0.25.
NextGen Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Earnings analysis for NextGen Healthcare Inc. [NXGN]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NXGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for NextGen Healthcare Inc. go to 4.51%.
Insider trade positions for NextGen Healthcare Inc. [NXGN]
There are presently around $917 million, or 78.30% of NXGN stock, in the hands of institutional investors. The top three institutional holders of NXGN stocks are: BLACKROCK INC. with ownership of 9,401,749, which is approximately -1.605% of the company’s market cap and around 3.80% of the total institutional ownership; VANGUARD GROUP INC, holding 6,504,833 shares of the stock with an approximate value of $117.54 million in NXGN stocks shares; and DIMENSIONAL FUND ADVISORS LP, currently with $42.94 million in NXGN stock with ownership of nearly -1.261% of the company’s market capitalization.
Positions in NextGen Healthcare Inc. stocks held by institutional investors increased at the end of January and at the time of the January reporting period, where 84 institutional holders increased their position in NextGen Healthcare Inc. [NASDAQ:NXGN] by around 5,231,395 shares. Additionally, 110 investors decreased positions by around 4,348,974 shares, while 24 investors held positions by with 41,154,946 shares. The mentioned changes placed institutional holdings at 50,735,315 shares, according to the latest SEC report filing. NXGN stock had 18 new institutional investments in for a total of 1,656,184 shares, while 27 institutional investors sold positions of 1,167,348 shares during the same period.